Cargando…
Serum level of octanoic acid predicts the efficacy of chemotherapy for colorectal cancer
The survival times of patients with advanced colorectal cancer (CRC) have increased due to the introduction of chemotherapy involving irinotecan and cetuximab. However, further studies are required on the effective pretreatment methods for identifying patients with CRC who would respond to particula...
Autores principales: | Iemoto, Takao, Nishiumi, Shin, Kobayashi, Takashi, Fujigaki, Seiji, Hamaguchi, Tetsuya, Kato, Ken, Shoji, Hirokazu, Matsumura, Yasuhiro, Honda, Kazufumi, Yoshida, Masaru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312949/ https://www.ncbi.nlm.nih.gov/pubmed/30655836 http://dx.doi.org/10.3892/ol.2018.9731 |
Ejemplares similares
-
The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy
por: Shoji, Hirokazu, et al.
Publicado: (2017) -
Immune status at pre-treatment impacts on progression-free survival of metastatic colorectal cancer patients treated with first-line chemotherapy
por: Tada, Kohei, et al.
Publicado: (2015) -
Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection
por: Shoji, Hirokazu, et al.
Publicado: (2014) -
Decylammonium octanoate
por: Jefferson, Andrew E., et al.
Publicado: (2011) -
Phase II study of lenvatinib for metastatic colorectal cancer refractory to standard chemotherapy: the LEMON study (NCCH1503)
por: Iwasa, Satoru, et al.
Publicado: (2020)